Calycosin, one of small molecules derived from astragalus, has anti-tumor effects in various
tumors. However, the effects of calycosin on papillary thyroid cancer (PTC) remain unclear. …

… preoperatory inflammatory markers and platelet indices in papillary thyroid cancer (PTC)
patients compared with patients with benign thyroid pathology. The secondary endpoints were …

… The 2015 ATA guidelines, which were released in January 2016, created a sea change in
thyroid surgery by stating that papillary thyroid cancers under 1 cm should receive TL, and that …

… In this paper, we have reported the establishment of a papillary thyroid cancer organoid
culture with an organoid forming efficacy of 7%, showing a prolonged self-renewal potential and …

… The worldwide incidence of papillary thyroid cancer (PTC) has increased dramatically in
recent decades. Although the 10-, 15-, and 20-year overall PTC survival rates are 97%, 95%, …

… Papillary thyroid cancer (PTC) is the most common thyroid malignancy with a high tendency
of lymph node metastasis (1). PTC is characterized by multifocality. Multifocal PTC (MPTC) …

… in opposite directions in papillary thyroid cancer patients. In our … in papillary thyroid cancer
patients, however, PE-NMe (18:1/18:1) was in opposite directions in papillary thyroid cancer …

… US examinations were performed by the same radiologist with expertise in thyroid cancer
at our institution using a 13-MHz linear transducer (Aplio 400; Toshiba, Tokyo, Japan). The Tg …

… The incidence of thyroid cancer has increased worldwide over the last decades. The
most common thyroid cancer subtype is papillary thyroid cancer (PTC). PTC management …

… NEAT1 (nuclear paraspeckle assembly transcript 1) is an oncogenic long non-coding
RNA (lncRNA) that facilitates tumorigenesis in multiple cancers. In papillary thyroid cancer (PTC), …